Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 334

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study

Armangue, Thaís, Olivé-Cirera, Gemma, Martínez-Hernandez, Eugenia, Sepulveda, Maria, Ruiz-Garcia, Raquel, Muñoz-Batista, Marta, Ariño, Helena, González-Álvarez, Veronica, Felipe-Rucián, Ana, Jesús Martínez-González, Maria, Cantarín-Extremera, Veronica, Concepción Miranda-Herrero, Maria, Monge-Galindo, Lorena, Tomás-Vila, Miguel, Miravet, Elena, Málaga, Ignacio, Arrambide, Georgina, Auger, Cristina, Tintoré, Mar, Montalban, Xavier, Vanderver, Adeline, Graus, Francesc, Saiz, Albert, Dalmau, Josep, Alcantud, Alberto, Aguilera-Albesa, Sergio, Alvarez Demanuel, Diana, Alvarez Molinero, Mireia, Aquino Fariña, Lourdes, Arrabal, Luisa, Arriola-Pereda, Gema, Aznar-Laín, Gemma, Benavides-Medina, Maite, Bermejo, Teresa, Blanco-Lago, Raquel, Caballero, Eva, Calvo, Rocío, Camacho Salas, Ana, Conejo-Moreno, David, Delgadillo-Chilavert, Verónica, Elosegi-Castellanos, Amagoia, Esteban Canto, Vanesa, Fernández-Ramos, Joaquín, Garcia-Puig, Montserrat, García-Ribes, Ainhoa, Gómez-Martín, Hilario, Gonzalez-Barrios, Desire, González-Gutiérrez-Solana, Luis, Jimena-Garcia, Sara, Jiménez-Legido, María, Juliá-Palacios, Natalia, López-Laso, Eduardo, Martí-Carrera, Itxaso, Martínez González, Marta, Martín-Viota, Lucía, Mattozi, Simone, Maqueda-Castellote, Elena, Mendibe, Maria D M, Mora-Ramírez, Maria D, Muñoz-Cabello, Beatriz, Navarro-Morón, Juan, Nunes-Cabrera, Tania, Orellana, Gabriela, Pujol-Soler, Berta, Querol, Luis, Ramírez, Alfredo, Rodriguez-Lucenilla, Maria I, Ruiz, Cesar, Soto-Insuga, Víctor, Toledo Bravo de Laguna, Laura, Turon-Viñas, Eulàlia, Vázquez-López, Maria, Villar-Vera, Cristina · 2020 · The Lancet Neurology

Abstract

BACKGROUND Investigations of myelin oligodendrocyte glycoprotein (MOG) antibodies are usually focused on demyelinating syndromes, but the entire spectrum of MOG antibody-associated syndromes in children is unknown. In this study, we aimed to determine the frequency and distribution of paediatric demyelinating and encephalitic syndromes with MOG antibodies, their response to treatment, and the phenotypes associated with poor prognosis. METHODS In this prospective observational study, children with demyelinating syndromes and with encephalitis other than acute disseminated encephalomyelitis (ADEM) recruited from 40 secondary and tertiary centres in Spain were investigated for MOG antibodies. All MOG antibody-positive cases were included in our study, which assessed syndromes, treatment and response to treatment (ie, number of relapses), outcomes (measured with the modified Rankin scale [mRS]), and phenotypes associated with poor prognosis. We used Fisher's exact and Wilcoxon rank sum tests to analyse clinical features, and survival Cox regression to analyse time to antibody negativity. FINDINGS Between June 1, 2013, and Dec 31, 2018, 239 children with demyelinating syndromes (cohort A) and 296 with encephalitis other than ADEM (cohort B) were recruited. 116 patients had MOG antibodies, including 94 (39%) from cohort A and 22 (7%) from cohort B; 57 (49%) were female, with a median age of 6·2 years (IQR 3·7-10·0). Presenting syndromes in these 116 patients included ADEM (46 [68%]), encephalitis other than ADEM (22 [19%]), optic neuritis (20 [17%]), myelitis (13 [11%]), neuromyelitis optica spectrum disorders (six [5%]), and other disorders (nine [8%]). Among the patients with autoimmune encephalitis in cohort B (n=64), MOG antibodies were more common than all neuronal antibodies combined (22 [34%] vs 21 [33%]). After a median follow-up of 42 months (IQR 22-67), 33 (28%) of the 116 patients had relapses, including 17 (17%) of 100 diagnosed at first episode. Steroids, intravenous immunoglobulin, or plasma exchange were used in 100 (86%) patients at diagnosis, and 32 (97%) of 33 at relapses. Rituximab was mainly used at relapses (11 [33%]). 99 (85%) of 116 patients had substantial recovery (mRS <2) and 17 (15%) moderate to severe deficits (mRS >2; one died). Phenotypes of poor prognosis included ADEM-like relapses progressing to leukodystrophy-like features, and extensive cortical encephalitis evolving to atrophy. Time to antibody negativity was longer in patients with relapses (HR 0·18, 95% CI 0·05-0·59). INTERPRETATION The spectrum of paediatric MOG antibody-associated syndromes is wider than previously reported and includes demyelinating syndromes and encephalitis. Recognition of these disorders has important clinical and prognostic implications. FUNDING Mutua Madrileña Foundation; ISCIII-Subdirección General de Evaluación y Fomento de la Investigación Sanitaria; Fondo Europeo de Desarrollo Regional; Pediatrics Spanish Society; Departament de Salut, Generalitat de Catalunya; Marato TV3 Foundation; Red Española de Esclerosis Múltiple; La Caixa Foundation; and Fundació CELLEX.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(19)30488-0

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 334

Metadata

Authors
Armangue, T., Olivé-Cirera, G., Martínez-Hernandez, E., Sepulveda, M., Ruiz-Garcia, R., Muñoz-Batista, M., Ariño, H., González-Álvarez, V., Felipe-Rucián, A., Jesús Martínez-González, M., Cantarín-Extremera, V., Concepción Miranda-Herrero, M., Monge-Galindo, L., Tomás-Vila, M., Miravet, E., Málaga, I., Arrambide, G., Auger, C., Tintoré, M., Montalban, X., Vanderver, A., Graus, F., Saiz, A., Dalmau, J., Alcantud, A., Aguilera-Albesa, S., Alvarez Demanuel, D., Alvarez Molinero, M., Aquino Fariña, L., Arrabal, L., Arriola-Pereda, G., Aznar-Laín, G., Benavides-Medina, M., Bermejo, T., Blanco-Lago, R., Caballero, E., Calvo, R., Camacho Salas, A., Conejo-Moreno, D., Delgadillo-Chilavert, V., Elosegi-Castellanos, A., Esteban Canto, V., Fernández-Ramos, J., Garcia-Puig, M., García-Ribes, A., Gómez-Martín, H., Gonzalez-Barrios, D., González-Gutiérrez-Solana, L., Jimena-Garcia, S., Jiménez-Legido, M., Juliá-Palacios, N., López-Laso, E., Martí-Carrera, I., Martínez González, M., Martín-Viota, L., Mattozi, S., Maqueda-Castellote, E., Mendibe, M. D. M., Mora-Ramírez, M. D., Muñoz-Cabello, B., Navarro-Morón, J., Nunes-Cabrera, T., Orellana, G., Pujol-Soler, B., Querol, L., Ramírez, A., Rodriguez-Lucenilla, M. I., Ruiz, C., Soto-Insuga, V., Toledo Bravo de Laguna, L., Turon-Viñas, E., Vázquez-López, M., & Villar-Vera, C.
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2020-03
Volume
19
Issue
3
Pages
234-246
ISSN
1474-4422 (ISSN-L)
OpenAlex
W3004592781
Cited by
334
References
27
FWCI
28.69
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study. https://app.cochat.ai/papers/10.1016/s1474-4422(19)30488-0
The paper
Armangue, T., Olivé-Cirera, G., Martínez-Hernandez, E., Sepulveda, M., Ruiz-Garcia, R., Muñoz-Batista, M., Ariño, H., González-Álvarez, V., Felipe-Rucián, A., Jesús Martínez-González, M., Cantarín-Extremera, V., Concepción Miranda-Herrero, M., Monge-Galindo, L., Tomás-Vila, M., Miravet, E., Málaga, I., Arrambide, G., Auger, C., Tintoré, M., . . . Villar-Vera, C. (2020). Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(19)30488-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.